Yokohama Biotech Firm To Market Hepatocytes From iPS Cells
This article was originally published in PharmAsia News
Executive Summary
Yokohama-based biotech venture firm Reprocell and the Japanese National Institute of Biomedical Innovation announces development of the world’s first human hepatocytes from induced pluripotent stem cells.